FDA Approves First Gene Therapy for GSDIa

The FDA has approved the first gene therapy for glycogen storage disease type 1a (GSDIa), marking a significant advancement in treatment options for this rare metabolic disorder.

This Wire brief sits within Fusion42's coverage of Biotech, and 2 sources have reported it.